Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
出版年份 2023 全文链接
标题
Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
作者
关键词
-
出版物
RMD Open
Volume 9, Issue 4, Pages e003487
出版商
BMJ
发表日期
2023-10-30
DOI
10.1136/rmdopen-2023-003487
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
- (2022) Natalia Mena-Vázquez et al. Journal of Clinical Medicine
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2022) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The impact of disease severity measures on survival in U.S. Veterans with rheumatoid arthritis-associated interstitial lung disease
- (2022) Rebecca Brooks et al. RHEUMATOLOGY
- Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies
- (2022) Jianbin Xu et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
- (2022) Marika Tardella et al. INFLAMMOPHARMACOLOGY
- Interstitial lung disease throughout the rheumatoid arthritis disease course
- (2021) Gregory C. McDermott et al. CURRENT OPINION IN RHEUMATOLOGY
- Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients
- (2021) Carlos Fernández-Díaz et al. RHEUMATOLOGY
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease
- (2021) Jeffrey A Sparks ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
- (2021) Esther F. Vicente-Rabaneda et al. AUTOIMMUNITY REVIEWS
- Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis–related interstitial lung disease: a meta-analysis
- (2021) Sisi Xie et al. CLINICAL RHEUMATOLOGY
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2021) Liana Fraenkel et al. Arthritis & Rheumatology
- Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
- (2020) Andreas Kerschbaumer et al. ANNALS OF THE RHEUMATIC DISEASES
- Management issues in rheumatoid arthritis-associated interstitial lung disease
- (2020) Bryant R. England et al. CURRENT OPINION IN RHEUMATOLOGY
- Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
- (2020) Giulia Cassone et al. Journal of Clinical Medicine
- Methotrexate and rheumatoid arthritis associated interstitial lung disease
- (2020) Pierre-Antoine Juge et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting
- (2020) Miriana d'Alessandro et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients
- (2020) Carlos Fernández-Díaz et al. RHEUMATOLOGY
- Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease
- (2020) Javier Narváez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
- (2020) Belén Atienza-Mateo et al. Journal of Clinical Medicine
- Pro-fibrotic effects of IL-17A and elevated IL-17RA in IPF and RA-ILD support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease
- (2019) Jie Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis
- (2019) Annalisa Fui et al. INTERNAL MEDICINE JOURNAL
- The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment
- (2019) Ana C Duarte et al. RHEUMATOLOGY
- Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis
- (2019) Izumi Kurata et al. INTERNAL MEDICINE
- Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study
- (2019) Andreina Manfredi et al. INTERNAL MEDICINE JOURNAL
- Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept
- (2018) Takeshi Mochizuki et al. Modern Rheumatology
- Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data
- (2018) Sanjoy Ketan Paul et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The GRADE Working Group clarifies the construct of certainty of evidence
- (2017) Monica Hultcrantz et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre
- (2017) Md Yuzaiful Md Yusof et al. RHEUMATOLOGY
- Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
- (2015) Joshua J. Solomon et al. EUROPEAN RESPIRATORY JOURNAL
- Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
- (2015) Bon San Koo et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study
- (2014) C. A. Kelly et al. RHEUMATOLOGY
- Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review
- (2013) Camille Roubille et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study
- (2010) Tim Bongartz et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started